Search results for "older patients"

showing 10 items of 78 documents

Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment

2016

Aim: Polypharmacy in older diabetics can have detrimental effects linked to poor adherence and the risk of drug interaction or more serious/frequent side effects. The aim of this study was to identify the characteristics associated with polypharmacy in a cohort of elderly diabetic patients being treated with oral hypoglycemic agents. Methods: The study population consisted of 1342 diabetic patients consecutively enrolled in 57 diabetes centers in Italy participating in the METABOLIC Study. Patients meeting the following inclusion criteria were enrolled: diagnosis of type 2 diabetes mellitus, age ≥65 years, and receiving oral antidiabetic treatment. Data concerning diabetes duration and comp…

Malemedicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismType 2 diabetesDiabetes Complications03 medical and health sciencesSex Factors0302 clinical medicineEndocrinologySurveys and QuestionnairesInternal medicineDiabetes mellitusType 2 diabetes mellitusmedicineOlder patientsInternal MedicineHumansHypoglycemic Agents030212 general & internal medicineMETABOLIC Study; Older patients; Polypharmacy; Type 2 diabetes mellitus; Endocrinology; Internal Medicine; Endocrinology Diabetes and MetabolismAgedAged 80 and overPolypharmacybusiness.industryAge FactorsType 2 Diabetes MellitusGeneral MedicinePrognosismedicine.diseaseMETABOLIC StudyDiabetes and MetabolismMalnutritionCross-Sectional StudiesEndocrinologyDiabetes Mellitus Type 2ItalyHealth Care SurveysCohortPolypharmacyPopulation studyFemalebusinessType 2 diabetes mellitus Older patients Polypharmacy METABOLIC StudyBody mass index
researchProduct

Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register

2019

In older adults infections are among the leading causes of emergency department visits, hospitalization, morbidity and mortality [1–3]. Infections also occur as adverse events during hospitalization, as highlighted by the large use of antibiotics in this setting, resulting in an increase of hospitalization length and mortality rate [4–6]. There is a paucity of studies, especially in European countries, that did offer a general pattern on all the types of infections occurring in acutely hospitalized older patients, being the literature mainly focused on single type of infections (i.e. pneumonia and urinary tract infections). To fill this gap of knowledge, we chose to observe and describe the…

Malemedicine.medical_specialtyMEDLINESocio-culturaleInfectionsComorbidities Hospitalizations Infections Older peopleComorbiditiesOlder patientsPatients' Rooms80 and overInternal MedicinePatients' Rooms.HumansMedicineLS4_4AgedAged 80 and overHospitalizationsbusiness.industryComorbidities; Hospitalizations; Infections; Older peopleHospitalizationPatient roomItalyRegister (music)Emergency medicineEmergency MedicineFemaleComorbidities; Hospitalizations; Infections; Older people; Aged; Aged 80 and over; Female; Hospitalization; Humans; Infections; Italy; Male; Patients' RoomsComorbiditieOlder peopleInfectionOlder peoplebusiness
researchProduct

In-hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI study.

2011

The aim of the study was to explore the association of dementia with in-hospital OBJECTIVE:The aim of the study was to explore the association of dementia with in-hospital death in acutely ill medical patients. METHODS: Thirty-four internal medicine and 4 geriatric wards in Italy participated in the Registro Politerapie SIMI-REPOSI-study during 2008. One thousand three hundred and thirty two in-patients aged 65 years or older were enrolled. Logistic regression models were used to evaluate the association of dementia with in-hospital death. Socio-demographic characteristics, morbidity (single diseases and the Charlson Index), number of drugs, and adverse clinical events during hospitalizatio…

Malemedicine.medical_specialtyPediatricsSettore MED/09 - Medicina InternaMEDLINECharlson indexLogistic regressionNOolder patientSex FactorsAcute illnesses Dementia Hospitalization Mortality Older patientsmental disordersmedicineDementiaHumansDementia diagnosisHospital MortalityIntensive care medicineAgedIn hospital deathAged 80 and overbusiness.industryacute illnessesConfoundingAge Factorsrisk of deathmedicine.diseaseSettore MED/45 - Scienze Infermieristiche Generali Cliniche E Pediatrichemortalityolder patientsacute illnessePsychiatry and Mental healthPneumoniahospital admissionLogistic ModelsAcute DiseaseDementiaFemaleGeriatrics and Gerontologybusinessdementia; risk of death; hospital admissionhospitalizationInternational journal of geriatric psychiatry
researchProduct

Frailty Is Associated with Oxidative Stress in Older Patients with Type 2 Diabetes

2021

Aging has increased the prevalence of frailty, and type 2 diabetes (T2D) has also increased in prevalence. Diabetes and oxidative stress (OS) have been shown to be related to frailty. However, the exact mechanism by which it occurs is not fully known. Our aim was to analyze body composition in community-dwelling older diabetic people treated in our center and to evaluate the possible relation between OS, frailty, and body composition. We included 100 adults older than 65 years with T2D. We found that 15% were frail and 57% were prefrail. The patients included in the nonrobust group showed increased levels of OS. Our study shows that the presence of T2D in the geriatric population is associa…

Malemedicine.medical_specialtyPopulationType 2 diabetesfrailtymedicine.disease_causeArticleCohort StudiesProtein CarbonylationOlder patientsGeriatric populationInternal medicineDiabetes mellitusMalondialdehydemedicinePrevalenceHumansoxidative stressTX341-641educationAgededucation.field_of_studybody compositionNutrition and Dieteticsdiabetesbusiness.industryNutrition. Foods and food supplyagingmedicine.diseaseDiabetes Mellitus Type 2Linear ModelsFemalebusinessOxidative stressFood ScienceNutrients
researchProduct

Home-based inspiratory muscle training for management of older patients with heart failure with preserved ejection fraction: does baseline inspirator…

2019

Background:Heart failure with preserved ejection fraction is a clinical syndrome characterised by reduced exercise capacity. Some evidence has shown that a simple and home-based programme of inspiratory muscle training offers promising results in terms of aerobic capacity improvement in patients with heart failure with preserved ejection fraction. This study aimed to investigate whether the baseline inspiratory muscle function predicts the changes in aerobic capacity (measured as peak oxygen uptake; peak VO2) after a 12-week home-based programme of inspiratory muscle training in patients with heart failure with preserved ejection fraction.Methods:A total of 45 stable symptomatic patients wi…

Malemedicine.medical_specialtyRehabilitation Nursing030204 cardiovascular system & hematologyBreathing Exercises03 medical and health sciences0302 clinical medicineOlder patientsInternal medicinemedicineHumans030212 general & internal medicineClinical syndromeAerobic capacityAgedHeart FailureAdvanced and Specialized NursingExercise Tolerancebusiness.industryInspiratory muscle trainingStroke VolumeInspiratory muscleExercise capacityHome basedinspiratory muscle functionaerobic capacityMedical–Surgical NursingHeart failure with preserved ejection fractionCardiologyFemaleCardiology and Cardiovascular MedicineHeart failure with preserved ejection fractionbusinessMuscle ContractionEuropean Journal of Cardiovascular Nursing
researchProduct

Spinal cord stimulation: An alternative concept of rehabilitation?

2017

Background: Chronic low back and leg pain is a disabling condition, affecting, in most cases, older patients with congenital or acquired spinal stenosis or patients with failed back surgery syndrome. Spinal cord stimulation has been introduced as an effective therapeutic option for those patients who have previously been operated without significant clinical benefits, or for all those patients who are ineligible for traditional surgery. Methods: We report our experience with ten patients treated with spinal cord stimulation plus medication and physical therapy between November 2014 and September 2015. Inclusion criteria were: previous surgical treatments for lumbar stenosis and metameric in…

Malemedicine.medical_specialtySpinal stenosismedicine.medical_treatmentArthrodesisSpinal cord stimulation03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationSpinal StenosisOlder patientsMedicineHumansFailed Back Surgery SyndromeLow backPhysical Therapy ModalitiesAgedPain MeasurementSpinal Cord StimulationRehabilitationLumbar Vertebraebusiness.industrySettore MED/27 - NeurochirurgiaLeg painMiddle Agedmedicine.diseaseDecompression SurgicalChronic low back painSurgeryBack Pain030220 oncology & carcinogenesisChronic low back painFemalebusiness030217 neurology & neurosurgeryFailed back surgery
researchProduct

Efficacy of pneumatic dilatation for the treatment of idiopatic achalasia: a single-center experience

2015

Pneumatic dilatation (PD) and Surgical Miotomy (SM) are presently the best treatments for untreated achalasia, with similar efficacy. There is no information on the relative efficacy of PD in younger compared to older patients. Aim of our study was to compare success rate and safety of PD in patients under fifty years old and in those over fifty years old affected by achalasia. Twenty consecutive symptomatic patients were treated in our Unit with graded PD under fluoroscopic view. Five male and 15 female with a median age of 47 years were treated. Twelve patients were less than fifty years old (group I) while 8 were older (group II). Median dysphagia questionnaire score was 14 and13 ingroup…

MarketingPharmacologySettore MED/12 - GastroenterologiaOrganizational Behavior and Human Resource Managementmedicine.medical_specialtyRelative efficacybusiness.industryStrategy and ManagementGroup iiComplete remissionPharmaceutical ScienceAchalasiamedicine.diseaseSingle CenterDysphagiaSurgerySettore MED/18 - Chirurgia Generaleachalasia pneumatic dilatation esophageal obstructionOlder patientsDrug DiscoverymedicineIn patientmedicine.symptombusinessAbdomen
researchProduct

General Symptomatology of Pathogenic Drug Usage in Old Patients

1984

Drug administration involves the risk of unwanted side effects in patients of any age. This risk is considerably higher in older patients,5 as is shown by several statistics on this subject.8, 16, 18, 21 Higher risk of unwanted side effects in aged subjects is due to the concomitance of a number of factors1,5,17 i. e

Old patientsmedicine.medical_specialtyOlder patientsbusiness.industryInternal medicinemedicineDrug administrationIn patientbusinessDrug usage
researchProduct

Midostaurin Plus Intensive Chemotherapy for Younger and Older Patients with Acute Myeloid Leukemia and FLT3 Internal Tandem Duplications

2021

Abstract BACKGROUND: Midostaurin is a first-generation, type I multi-targeted kinase inhibitor with inhibitory activity against FLT3-ITD and -TKD mutations. Midostaurin is approved by FDA and EMA in combination with intensive induction and consolidation chemotherapy for adult patients with AML exhibiting an activating FLT3 mutation; the EMA label also includes single-agent maintenance therapy following consolidation chemotherapy. We conducted a phase-II trial (AMLSG 16-10) to evaluate midostaurin with induction chemotherapy followed by allogeneic hematopoietic-cell transplantation (HCT) and a one-year midostaurin maintenance therapy in younger and older patients with acute myeloid leukemia …

Oncology0303 health sciencesmedicine.medical_specialtybusiness.industryImmunologyMyeloid leukemiaCell BiologyHematologyIntensive chemotherapyBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineOlder patientschemistryInternal medicinemedicineMidostaurinbusiness030304 developmental biology030215 immunologyBlood
researchProduct

Special Situations in APL

2017

The introduction of all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) as the mainstay therapy of acute promyelocytic leukemia (APL) has drastically changed the outcome of this hematologic malignancy into one of the first to receive a targeted treatment. Using frontline treatment strategies including these agents in combination with standard cytotoxic drugs has provided outstanding therapeutic results in most patients. In spite of the achievement of brilliant results in the majority of patients, some special situations still require the implementation of changes from the conventional therapeutic approach. In this chapter, we will review and discuss the management of APL in older and …

OncologyAcute promyelocytic leukemiamedicine.medical_specialtybusiness.industryGenetic variantsmedicine.diseaseLeukemiachemistry.chemical_compoundTherapeutic approachchemistryOlder patientsInternal medicinemedicineHematologic malignancyTreatment strategyArsenic trioxidebusiness
researchProduct